191 related articles for article (PubMed ID: 12694340)
1. Fabry disease: diagnosis and treatment.
Breunig F; Weidemann F; Beer M; Eggert A; Krane V; Spindler M; Sandstede J; Strotmann J; Wanner C
Kidney Int Suppl; 2003 May; (84):S181-5. PubMed ID: 12694340
[TBL] [Abstract][Full Text] [Related]
2. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.
Breunig F; Wanner C
J Nephrol; 2008; 21(1):32-7. PubMed ID: 18264934
[TBL] [Abstract][Full Text] [Related]
3. Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease.
Prabakaran T; Birn H; Bibby BM; Regeniter A; Sørensen SS; Feldt-Rasmussen U; Nielsen R; Christensen EI
Nephrol Dial Transplant; 2014 Mar; 29(3):619-25. PubMed ID: 24215016
[TBL] [Abstract][Full Text] [Related]
4. Fabry disease: treatment and diagnosis.
Rozenfeld PA
IUBMB Life; 2009 Nov; 61(11):1043-50. PubMed ID: 19859978
[TBL] [Abstract][Full Text] [Related]
5. [Fabry Disease: Pathogenesis, Clinical Symptoms, and Treatment with Enzyme Replacement Therapy].
Sawai S
Brain Nerve; 2015 Sep; 67(9):1099-108. PubMed ID: 26329150
[TBL] [Abstract][Full Text] [Related]
6. Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes.
Kim JH; Lee BH; Hyang Cho J; Kang E; Choi JH; Kim GH; Yoo HW
J Hum Genet; 2016 Nov; 61(11):923-929. PubMed ID: 27334365
[TBL] [Abstract][Full Text] [Related]
7. Fabry disease and cardiovascular involvement.
Anastasakis A; Papatheodorou E; Steriotis AK
Curr Pharm Des; 2013; 19(33):5997-6008. PubMed ID: 23448453
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for diagnosis, therapy and follow up of Anderson-Fabry disease.
Kes VB; Cesarik M; Zavoreo I; Soldo-Butković S; Kes P; Basić-Jukić N; Racki S; Jakić M; Delić-Brkljacić D; Jukić Z; Trkanjec Z; Serić V; Solter VV; Bielen I; Basić S; Demarin V; ; ; ;
Acta Clin Croat; 2013 Sep; 52(3):395-405. PubMed ID: 24558776
[TBL] [Abstract][Full Text] [Related]
9. Fabry Cardiomyopathy: Current Practice and Future Directions.
Yim J; Yau O; Yeung DF; Tsang TSM
Cells; 2021 Jun; 10(6):. PubMed ID: 34204530
[TBL] [Abstract][Full Text] [Related]
10. Anderson-Fabry disease: developments in diagnosis and treatment.
Mehta AB
Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S66-74. PubMed ID: 20040315
[TBL] [Abstract][Full Text] [Related]
11. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study.
Weidemann F; Breunig F; Beer M; Sandstede J; Turschner O; Voelker W; Ertl G; Knoll A; Wanner C; Strotmann JM
Circulation; 2003 Sep; 108(11):1299-301. PubMed ID: 12952834
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features, Diagnosis, and Management of Patients With Anderson-Fabry Cardiomyopathy.
Yogasundaram H; Kim D; Oudit O; Thompson RB; Weidemann F; Oudit GY
Can J Cardiol; 2017 Jul; 33(7):883-897. PubMed ID: 28668140
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for Fabry disease.
Siatskas C; Medin JA
J Inherit Metab Dis; 2001; 24 Suppl 2():25-41; discussion 11-2. PubMed ID: 11758676
[TBL] [Abstract][Full Text] [Related]
14. Anderson-Fabry disease: developments in diagnosis and treatment.
Kes VB; Cesarik M; Zavoreo I; Madzar Z; Demarin V
Acta Clin Croat; 2012 Sep; 51(3):411-7. PubMed ID: 23330407
[TBL] [Abstract][Full Text] [Related]
15. Cardiac magnetic resonance imaging illustrating Anderson-Fabry disease progression.
Imbriaco M; Messalli G; Avitabile G; Cuocolo A; Maurea S; Soscia F; Pisani A
Br J Radiol; 2010 Dec; 83(996):e249-51. PubMed ID: 21088081
[TBL] [Abstract][Full Text] [Related]
16. Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy.
Mignani R; Feriozzi S; Pisani A; Cioni A; Comotti C; Cossu M; Foschi A; Giudicissi A; Gotti E; Lozupone VA; Marchini F; Martinelli F; Bianco F; Panichi V; Procaccini DA; Ragazzoni E; Serra A; Soliani F; Spinelli L; Torti G; Veroux M; Cianciaruso B; Cagnoli L
Nephrol Dial Transplant; 2008 May; 23(5):1628-35. PubMed ID: 18057066
[TBL] [Abstract][Full Text] [Related]
17. [Fabry disease: An overlooked diagnosis in adult cardiac patients].
Kayıkçıoğlu M; Şimşek E; Kalkan Uçar S; Bayraktaroğlu S; Onay H; Sözmen E; Çoker M
Turk Kardiyol Dern Ars; 2017 Sep; 45(6):549-555. PubMed ID: 28902648
[TBL] [Abstract][Full Text] [Related]
18. Fabry disease--a primer for cardiologists.
Mursă A; Ginghină C; Jurcut R
Rom J Intern Med; 2014; 52(4):216-22. PubMed ID: 25726623
[TBL] [Abstract][Full Text] [Related]
19. [Fabry disease in childhood].
Chabrol B; Mansour H; Cano A
Presse Med; 2007 Mar; 36 Spec No 1():1S32-5. PubMed ID: 17546765
[TBL] [Abstract][Full Text] [Related]
20. Fabry disease: focus on cardiac manifestations and molecular mechanisms.
Perrot A; Osterziel KJ; Beck M; Dietz R; Kampmann C
Herz; 2002 Nov; 27(7):699-702. PubMed ID: 12439642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
